On 21 March 2018, orphan designation (EU/3/18/2003) was granted by the European Commission to Pharmadev Healthcare Ltd, Ireland, for ribavirin for the treatment of Lassa fever.
The sponsor’s address was updated in April 2021.
|Disease / condition||
Treatment of Lassa fever
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.